Literatur
American Academy of Pediatrics (2009) Committee on infectious diseases. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 123:1412–1420
Berner R, Schumacher RF, Hameister S, Forster J (1999) Occurrence and impact of community-acquired and nosocomial rotavirus infections-a hospital-based study over 10 years. Acta Paediatr Suppl 88(426):48–52
Centers for Disease Control and Prevention (CDC) (2008) Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007–May 2008. Morb Mortal Wkly Rep 57(25):697–700
Deutsche Akademie für Kinder- und Jugendmedizin (2006) Empfehlungen zur Rotavirusimpfung. http://www.dakj.de
Giaquinto C, van Damme P, Huet F et al (2007) Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis 195 (Suppl 1):S26–S35
Giaquinto C, van Damme P, Huet F et al (2007) Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 195 (Suppl 1):S36–S44
Gleizes O, Desselberger U, Tatochenko V et al (2006) Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 25 (1 Suppl):S12–S21
Goveia MG, Rodriguez ZM, Dallas MJ et al (2007) Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 26(12):1099–1104
Koletzko S, Lentze MJ (2008) Akute infektiöse Gastroenteritis. www.awmf.de
Parashar UD, Hummelman EG, Bresee JS et al (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565–572
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354(1):11–22
van Damme P, Giaquinto C, Huet F et al (2007) Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis 195 (Suppl 1):S4–S16
Vesikari T, Giaquinto C, Huppertz HI (2006) Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J 25 (1 Suppl):S42–S47
Vesikari T, Matson DO, Dennehy P et al (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354(1):23–33
Vesikari T, van Damme P, Giaquinto C et al (2008) European society for paediatric infectious diseases/European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Evidence-Based Recommendations for Rotavirus Vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr 46:615–618
Author information
Consortia
Rights and permissions
About this article
Cite this article
Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) e.V.., Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) e.V.. Stellungnahme zur Rotavirusimpfung. Monatsschr Kinderheilkd 157, 914–916 (2009). https://doi.org/10.1007/s00112-009-2054-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-009-2054-2